- Login
- Register & Subscribe
- Language: EN FR DE
Five new medicines, including a cell-based treatment for cartilage defects, have received positive opinions from the European Medicines Agency, paving the way for the issuing of marketing authorisations by the European Commission.
United Kingdom
Friday August 20 2010
Friday August 20 2010
Thursday August 19 2010
Thursday August 12 2010
Tuesday August 10 2010